drugset / Trial / NCT04123483

EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders

NCT04123483 ↗

Phase 4 Withdrawn Massachusetts General Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess a novel nutritional supplement developed for prenatal health and mood benefits, and to determine whether there is preliminary evidence for efficacy in Menstrual Related Mood Disorders (MRMD), including PMS with Prominent Mood Symptoms and PMDD.

Timeline

Start
2019-11
Primary completion
2021-11
Completion
2022-11

Outcome

Outcome not reported

Stopped (Business): “Cancellation of funding contract”

Drugs

EvaluationDrugModalityDoseRoute
Subject EnBrace HR Unknown — —